High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
about
KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysisPathology and molecular genetics of pancreatic neoplasms.Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.Intraductal papillary mucinous neoplasm of the pancreas: an updateGenomic landscapes of pancreatic neoplasia.Pathological and molecular evaluation of pancreatic neoplasms.PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitorsLoss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy.The genetic classification of pancreatic neoplasia.Role of emerging molecular markers in pancreatic cyst fluid.Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.Loss of PTEN and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.
P2860
Q26741895-D1D1D333-D475-4A27-A6F4-0701BE08B7CFQ33581119-B459C7F3-7853-4D9B-AE1C-521629A8AD48Q33754040-4C70D797-9DD7-439D-A272-5D46C7C254F1Q33988909-D5FC098A-CCDF-4AE0-8644-59614471C016Q34657866-53CC0041-9867-484A-B5CD-2224FB0E819AQ35170720-AC11C73E-43FC-45F0-AFE8-23E6ED3D0D7EQ35670143-B413CF11-5D89-47CB-9E3C-115824388943Q36245945-446CCED7-B461-4C9B-8018-F05EA52032A6Q37558614-85F63BA9-FAC0-48AE-A6BB-F84514C3A4F2Q38113752-CAC3DB58-64AF-42B0-BC8E-47C85D5E62D4Q38326191-2DCB5202-FF95-43A8-A1BF-5470D488AC6BQ38661563-06F37272-A397-42FC-B006-C5C8147B97E3Q40437996-B928769E-D7FD-4468-8B6B-88B38E1C7785Q47259787-92613A9F-7699-44EA-B432-82D31A4760C7Q50101175-1E3766F8-889F-4238-BEE5-0DD33304CF7A
P2860
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@ast
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@en
type
label
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@ast
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@en
prefLabel
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@ast
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@en
P2093
P2860
P1476
High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).
@en
P2093
Eli Brazowsky
Gideon Rechavi
Joseph M Klausner
Menahem Ben-Haim
Nir Lubezky
Sylvia Marmor
Yoram Cohen
P2860
P2888
P304
P356
10.1007/S11605-010-1411-8
P577
2011-01-12T00:00:00Z